Pharmaron Biologics and Cell & Gene Therapy

Pharmaron: Global Life Sciences Services Provider Stock Code: 300759.SZ/3759.HK Founded in 2004, Pharmaron is a leading life sciences service provider offering integrated Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) solutions across the biologics and cell and gene therapy (CGT) development spectrum - from discovery to market. With a global presence, advanced technologies, and regulatory expertise, we help partners accelerate timelines, reduce risks, and bring innovative therapies to patients faster. Biologics and CGT Solutions ----------------------------------------------- > Antibody Discovery and Protein Science – Supporting biologics programs from discovery to clinical development. > Developability Assessment – Evaluating candidate molecules for manufacturability and therapeutic potential. > Process Development – Optimizing and scaling upstream and downstream processes. > Small-Scale Non-GMP and cGMP Manufacturing – Flexible production solutions for early development and clinical-scale needs. > Analytical and Quality Control – Comprehensive testing to ensure product integrity and compliance. > Regulatory Support – Guidance for global submissions, including IND and BLA filings. > CGT Laboratory Services – In vitro assays, in vivo studies, biodistribution, and bioanalysis. > Gene Therapy CDMO Services – Plasmid DNA manufacturing, viral vector development, and GMP manufacturing. Connect with us to explore how Pharmaron can support your journey from discovery to market Biologics & Cell and Gene Therapy | Pharmaron Keywords: CRO, CDMO, biologics development, CGT, antibody discovery, protein science, developability assessment, process development, cGMP manufacturing, analytical development, quality control, regulatory affairs, IND, BLA, cell and gene therapy (CGT)